Using the Female Sexual Function Index (FSFI) for investigating female sexual function has become widespread. A score of 26.5 has been suggested as delineating 'functional' from 'dysfunctional' women. This study aimed to understand in greater detail what contributes to changes in women's FSFI scores while their partners are taking oral erectile medications for erection problems. Couples randomized to receive two erectile medications for two 3-month phases, completed questionnaires. FSFI scores were augmented by individual interviews at baseline, 3 and 6 months, in order to better understand what the scores meant in the context of ED medication use. In all, 50% of the women scored o26.5 at baseline; of these 56% recovered by 6 months. A number of 'dysfunctional' women recorded low FSFI scores solely as a result of their partner's ED. Overall, 22% were still 'dysfunctional' at 6 months, but one third of these appeared 'functional' at 3 months. A further group of women continued to record low scores despite reporting much improved sexual satisfaction. The women's interviews elaborate on their FSFI results, with five themes emerging to provide more clarity about the relative changes seen in a prospective study situation, and potentially in clinical practise contexts. The increasing use of questionnaires to determine sexual function should be supplemented with good clinical interviewing. The interview details explain how FSFI fluctuations occurred and contain clinical implications for research and practise in the area of couple's sexuality. 14-16 Women with FSFI scores concomitant with sexual dysfunction (o26.5) were excluded from some studies because of the potential of such 'dysfunction' to have a negative impact on the effect of men's ED treatments on the couples. 10, 11 However, a recent treatment study, that included all women regardless of their dysfunctional status, reported that once the man's ED had been effectively treated the putative 'dysfunction' was no longer present in many of the women. 16 Although these reports, based on the standardized measures, detail overall changes in the women's sexual function as their partners were treated, they do not describe why the women experience improvement in their sexual function.
Introduction
Recent studies have demonstrated the impact of men's ED on their female partners. [1] [2] [3] [4] [5] [6] [7] [8] Treatment of men with ED with oral phosphodiesterase type 5 inhibitors (PDE5i) has also been reported to have positive benefits for their female partners. [9] [10] [11] [12] Most of these studies have relied on standardized sexual function (for example, Female Sexual Function Index (FSFI)) 13 and treatment satisfaction questionnaires. [14] [15] [16] Women with FSFI scores concomitant with sexual dysfunction (o26.5) were excluded from some studies because of the potential of such 'dysfunction' to have a negative impact on the effect of men's ED treatments on the couples. 10, 11 However, a recent treatment study, that included all women regardless of their dysfunctional status, reported that once the man's ED had been effectively treated the putative 'dysfunction' was no longer present in many of the women. 16 Although these reports, based on the standardized measures, detail overall changes in the women's sexual function as their partners were treated, they do not describe why the women experience improvement in their sexual function.
Several studies reporting women's sexual function changes during their partner's ED treatment show disparities in the effects on women of treating men's erection problems. In studies employing the FSFI, domains in which improvement has been reported include arousal, lubrication, orgasm, satisfaction and overall scores. 11, 16, 17 Although the FEMALES study reported improvements in women's sexual desire, 11 neither Cayan et al. 17 nor Conaglen et al., 16 found significant improvements in that domain. Further, the Goldstein et al. 11 paper reported no pain changes, whereas Cayan et al. 17 and Conaglen et al. 16 both reported improvements in women's levels of pain once their partner's ED was treated. The findings from the FEMALES study may have been influenced by it being retrospective and excluding women reporting pain at baseline. The present prospective study, which included all women, irrespective of their FSFI score, sought to clarify the extent to which the problems reported by female partners of men with ED are the result of the man's ED or other factors.
The current study interviewed women whose partners experienced ED and were completing treatment for a period of 6 months with two of the available oral ED medications (sildenafil; Viagrat, Pfizer; and tadalafil; Cialist, Eli Lilly). Our principal aim was to understand the women's sexual issues, their perceptions of how their sexual problems developed, and what the impact of the men's treatment might be for the women. To this end, we used the FSFI scores as a guide, bearing in mind that these measures are insufficient in themselves to make diagnoses of sexual dysfunction. We particularly focused on the women whose FSFI scores indicated that they experienced sexual problems. These women were tracked during treatment of their partner's ED, in order to understand the impact their partner's ED treatment had on their sexual functioning.
Patients and methods

Participants
The data for this study came from a sample of 100 women in New Zealand, whose partners were experiencing ED, determined by an erectile function subscale score p20, from the International Index of Erectile Dysfunction. 18 Participants were obtained through convenience sampling via advertisements for study volunteers placed in the local newspaper. All participants signed individual informed consents, and the study was approved by the national ethics review committee, in accordance with Declaration of Helsinki protocols. Participants ranged from 30 to 75 years of age, with a mean age of 53 years (s.d. ¼ 8.89), and the majority were Caucasian (83%). In all, 82% of the women were married to their partners, and had been in the present relationship from between 3 months to 52 years, with a mean duration of 23 years (s.d. ¼ 14.95).
Materials
The women completed the FSFI 13 at baseline, middle (after 3 months) and at the end of the study (after 6 months). This questionnaire has been used frequently in studies of women's sexual function and provides a snapshot of a woman's function over the previous 4 weeks, and changes due to therapy. To elaborate on that measure, in-depth, semistructured interviews were conducted at each study contact point. The interview protocol included questions that explored aspects of women's own sexual dysfunction and, if relevant, how it related to their partner's ED. For example, women were asked, 'Do you have any problems yourself with desire?' We wanted to understand whether other issues influenced the women's reported levels of sexual function, their experience of sexual pleasure, sense of self as sexually attractive and so on. As the partners experienced the two ED treatments, the women were asked how their own sexual functioning was affected (see Appendix for interview outlines).
Procedure
The majority of women participated in face-to-face interviews, which were digitally recorded to enable repeated review during the analytical process. Interviews lasted B20 min each. Interviews were transcribed from the digital recordings, and then coded using NVivo software version 8 (2008, QSR International Pty Ltd., Doncaster, Victoria, Australia). Coding and analysis were carried out utilizing principles from interpretative phenomenological analysis. 19 Using this approach, transcripts were examined one by one, grouping extracts into relevant themes as they emerged. As the iterative analysis continued, themes were constantly revised and extended until no further themes could be identified, and the resulting framework accounted for all relevant extracts found within the transcripts. A secondary coder, external to the project, coded 10% of the interviews, to ensure consistency of emerging themes. From the analysis, a number of main themes were identified. These themes were compared with the quantitative information from the FSFI in order to clarify the detail behind the questionnaire data, and thus better understand the clinical reality for women whose partner is experiencing ED.
Results
Quantitative
Of the 96 women who completed the study, 48 (50%) recorded baseline FSFI scores lower than the 26.5 score considered to differentiate sexually functional from dysfunctional women. 20 Of these, 27 improved to 'functional' levels by the end of the study. Within that cluster, 14 women attributed their initial low levels of sexual function to their partner's ED and reported no sexual problems of their own. A further seven women reported that they experienced Sexual dysfunction in female partners of men with ED HM Conaglen et al dryness during sexual activity, that they managed either by using lubricants during sex or an oestrogen cream. These women related the dryness to their own hormonal status rather than their partner's ED. Five women reported low sexual desire as a result of their partner's ED, and another woman reported pain as a result of her partner's erection being of poor quality before treatment. A further group of 21 women remained 'dysfunctional' at the end of the study, but of these, seven had been 'functional' at study mid-point. In addition, we found that seven of the women who reported being 'functional' at baseline became 'dysfunctional' by the end of the study, despite their partner's ED treatment. A summary of the women's groupings can be seen in Table 1 . This table separates each theme as it related to the desire, arousal and pain problems described by the women. 
Qualitative
The analysis of the interview data revealed that although women were asked about dysfunction related to desire, arousal and pain separately during the interviews, five common themes emerged as reasons for women's experience of each type of sexual dysfunction: physical reasons (including medical problems), menstruation and/or menopause issues, and psychological reasons including stress and fatigue, relationship issues and issues related to the partner's ED. These themes are considered below, and the FSFI scores of the women represented by the various themes are included to indicate what happened for the women during the 6 months of the study.
Physical reasons
Menstruation and menopause. The most common reasons for female experiences of sexual dysfunction were linked to menstruation and menopause, whether related to endometriosis, hormone replacement therapy, the contraceptive pill or vaginal dryness:
'At age 41 I had tests and I went on to hormone replacement therapy and I was on it for a lot of years. I ran out one Christmas over a holiday period and the migraines stopped. So I went back to the doctor and I said 'what am I going to do?' and he said 'you can either keep taking the hormone replacement therapy and have great sex and lots of migraines or the other way round', and I chose the no migraines, thank you very muchy there are hassles because I've goty Um, lack of lubrication, lower libido, I'm nowhere near as interested. Yeah, I have to really work at it and keep track of how often, so if I think 'ooh, we haven't done it in a little while' then I start to think I should do something about it.' (#61, aged 54, duration of relationship 15 years, FSFI baseline, 27.1; 3 months, 29.4; 6 months, 29.3) 'I think orgasm, since menopause, is definitely slower. Yeah, I still get there but I think you've got to work a bit harder to be aroused.' (#22, aged 54, duration of relationship 31 years, FSFI baseline, 28.2; 3 months, 29.3; 6 months, 29.7)
'I do find that I'm having, when the uterus dries, I find that I'm getting like a smarty little irritation, kind of feels like it's round my waterworks, and so that's kind of like, I don't really want to be touched, and it's just yeah, don't go there sort of thing, you know, that sort of irritation.' (#44, aged 57, duration of relationship 12 years, FSFI baseline, 26.6; 3 months, 26.5; 6 months, 23.5) 'There were sometimes when I had pain with intercourse, but that hasn't happened for a long time, I think it had something to do with the endometriosis. Quite intense, sort of right up inside. But it depended on the position, so it would just be a case of stopping and trying something else.' (#38, aged 35, duration of relationship 15 years, FSFI baseline, 3.8; 3 months, 31.8; 6 months, 26.2)
The first two women here recorded no sexual dysfunction throughout the study, but the latter two, while recording functional scores on at least one FSFI (#44 at baseline and mid-point of study; #38 at mid-point), remained dysfunctional at the end of the study.
A number of women in the current sample had medical issues such as human papilloma virus, vaginitis, obesity or operations that impacted their sexual functioning: However, despite their medical problems, all of these women recorded functional scores on the FSFI throughout the study.
Psychological reasons
Stress and fatigue. Women experiencing arousal and pain issues did not link these problems to stress or fatigue. However, a number of women attributed desire issues to these factors: 'Well, it takes a while to get, I'm always so tired because I work so hard, I don't have a desire, (partner) can look at me and say to me, right, book me in for tonight, oh, or something, it's a hassle for me. It's always going to be a hassle, but once we get going I'm fine, and it works out well.' (#20, aged 42, duration of relationship 11 years, FSFI baseline, 22.4; 3 months, 27.6; 6 months, 27.2) 'Well it's quite strange actuallyy Lack of interest perhaps brought on by fatigue, I mean everything sort of revolves around that.' (#67, aged 48, duration of relationship 27 years, FSFI baseline, 29.7; 3 months, 28.5; 6 months, 29)
The first woman was no longer dysfunctional once her partner was treated in the study, and the second never fell below the cut-off level; she did speak about tiredness and lessened interest when interviewed though.
Relationship issues. As with stress and fatigue, lack of desire was linked with psychological reasons in addition to physical reasons: 'Of course, the desire and the arousal depend so much on the situation, and a lot of different things come into it. And I can, in the past, I can remember being so aroused, and so full of wanting to get going, but when you kind of get into a relationship, and you've been together for quite a long time, things change. So I don't feel a lot of desire now, but what I'm wanting is the closeness, and I'm wanting it for (partner), so that he can, you know, experience that again.' (#14, aged 66, duration of relationship 18 years, FSFI baseline, 22.3; 3 months, 22.7; 6 months, 23.5) 'I think I fairly quickly discovered in this relationship, in the sexual relationship, that there seemed to be kind of a power issue in the bed, in that, because I was used to being able to be really quite assertive around sex, and be the one to make the approaches, and I found that with (partner) that was not the way he wanted to go at all, he wanted to be the one to be making the approaches. And so I feel that I actually, in order to keep some sexual relationship going, I do feel like I compromised my power, my sexual power. yI find that I'm not sort of getting things coming my way, then I don't tend to want to be stimulating him either, so yeah, so I sort of think that's probably some of that lack of sexual desire on my part too, it's kind of a shutting down of myself around that stuff.' (#44, aged 57, duration of relationship 12 years, FSFI baseline, 26.6; 3 months, 26.5; 6 months, 23.5).
The first woman quoted recorded dysfunctional scores throughout the study although her later scores improved on the baseline, but the latter woman's desire levels and overall function declined slightly during the study. However, her levels of sexual satisfaction rose over the study duration.
Issues related to partner's ED. There was a range of ways that the partner's ED impacted the women's own sexual functioning. Some women experienced emotional distancing and a lack of intimacy, which then impacted their levels of desire and arousal, whereas others experienced frustration and a lack of satisfaction with their sexual experiences with their partner, which then also led to their own dysfunction:
'I just feel, over the last two years, and especially in the last twelve months, I've got to the stage where I really can't be botheredy And then he gets annoyed, and I can understand that, but it's not very good from my point of view either, I mean, you just start to get interested, and then nothing, he either can't get an erection, or he comes quickly, and then you're left sitting there wondering what it was all about.' (#48, aged 53, duration of relationship 9 years, FSFI baseline, 19.4; 3 months, 30.7; 6 months, 29). Problems with erection quality also resulted in women experiencing discomfort and problems with their own sexual functioning: 'I've had sexual pain only when he's trying to penetrate when he's not fully erect, and it's really uncomfortable. I don't quite know how to describe it. Probably because unconsciously you're uptight, you're not as relaxed, because you know that he's uptight and you're thinking 'oh for goodness' sake'.' (#89, aged 51, duration of relationship 15 years, FSFI baseline, 21; 3 months, 31.2; 6 months, 29.3).
All of the women in this group did improve during the study, confirming their assessment that the problems they experienced were based on their partner's ED.
However, a number of women talked about their partner's ED resulting in them having a lack of sexual confidence, which then resulted in their own sexual dysfunction:
'Well that's the thing really, we don't really know why. I guess if the other person doesn't want to do it, you may feel as if you're less desirable to them. And it's not so much the dysfunction in itself, from my point of view, but the fact that possibly you're the cause of it because you're not, as I was saying, not so desirable.' (#87, aged 55, duration of relationship 37 years, FSFI baseline, 17.3; 3 months, 24.8; 6 months, 15.6).
'It's starting to impact on me now and in fact my confidence is being dented. So I don't feel as comfortable as I used to when we do have sex.' (#90, aged 35, duration of relationship 6 years, FSFI baseline, 15.9; 3 months, 22.9; 6 months, 24.1).
These women remained 'dysfunctional' through the study, but the younger of the two did experience marked improvement over the 6 months, as her confidence returned once her partner was treated.
There were a number of women who linked their dysfunction to a combination of their own issues and their partner's ED: 'I've never had a period since, so I presume I've gone through menopause. My only grump is lack of libido; that is definitely a problem. But whether that's now linked to (partner)'s problem, in the last couple of years, to me I've been tailing down, whether it's been stress, we've made a big move to a new country, and all sorts of thingsy' (#53, aged 52, duration of relationship 27 years, FSFI baseline, 22.9; 3 months, 28.1; 6 months, 31.8).
'And not only that, things like, I know he thinks that I'm always trying to get out of it, but things like arthritis, you know, my legs hurt. And I do have, when I have my legs up, well I have to have them down, because my legs start hurting real bad. And then of course, because his erection isn't very hard, then it comes out, and then he gets angry, because I, 'you didn't want to do it anyway', well, I just can't. You're at that age, you just have got all these problems now, and it's not just him with the problems, it's me too. But I can't get that through his head, he thinks I'm just trying to get out of it. So it's easier just to let him think that, than go on about my problems.' (#2, aged 52, duration of relationship 32 years, FSFI baseline, 21.2; 3 months, 30.2; 6 months, 31.3).
These women did well during the study with improved scores recorded at each stage after treatment of their partner's problems.
In summary, Table 2 shows the number of women who experienced problems in each of the area of dysfunction at the beginning of the study, and the reasons they gave for the dysfunction. The comparison of FSFI and interview data has clarified how women with particular difficulties have progressed in this 6-month study where their male partners were treated for their ED.
Discussion
This mixed methods study further elaborates on the questionnaire results on the sexual functioning of women whose partners experience ED, reported in previous treatment studies. [1] [2] [3] [4] [5] [6] [7] [8] The majority of the women, whose partners were treated with PDE5i for 6 months, experienced improvements in their own sexual function, a finding that accords with earlier studies. 12 However, as reported in earlier papers, those that recorded lower levels of functioning on the FSFI were not necessarily dissatisfied with their partners' treatment. 9, 16 In terms of the FSFI satisfaction scale, more than half of these women still recorded X3 out of 6, and many of the women expressed a wish for their partners to continue using PDE5i to benefit the couples sexual experiences. The women's interviews revealed a number of themes allowing a fuller appreciation of the many determinants of women's sexual functioning.
The interview data also explained how women's lack of interest in unsuccessful sex was addressed by the PDE5i treatment taken by their partner. Stress Sexual dysfunction in female partners of men with ED HM Conaglen et al and fatigue related desire issues were no longer present once partners were treated for their ED, which demonstrates a wider benefit for couples of correcting ED. Those few who failed to improve, related their desire problems to relationship difficulties.
It has been noted that the scale used (FSFI) emphasises desire that precedes arousal, rather than any that might be experienced as arousal develops in the sexual situation. 21 A woman experiencing problems relating to her partner may not feel desire before arousal, and thus be labelled as less functional. However, as has been stated before, where relationship issues are the basis for a woman's sexual problems, treatment of the man's ED might not result in a concomitant recovery of the woman's sexual function. 1, 8 A detailed understanding of changes in sexual desire in a small proportion of the women in the present study may explain how previous studies have found more widespread changes in women's sexual desire. However, the majority of the women in our study had an interest in, and desire for improved sexual experiences at the start of the study, so it is not surprising that the desire changes once their partners were treated for ED were not significant.
There were, however, some women whose FSFI remained dysfunctional at the end of the study; these fell into two groups: one where functional FSFI scores had never been reached (n ¼ 7) and another where the 'functional' cutoff was reached at mid-point, then a decrease was experienced by the end of study (n ¼ 7). Most of the women in the first subgroup had issues with illness, medication or family problems. Two women in the first subgroup and the majority of the second subgroup reported that they disliked the product their partner was using in phase two of the study, which in turn affected their sexual function. 9 This finding underlines the importance of understanding the female partner's preference regarding PDE5i use by men with ED. 9, 16 Women whose sexual problems were arousal, lubrication or pain experienced positive benefits from their partner's treatment, where the problems were related to their partners ED. However, fewer women whose sexual dysfunction related to their own medical or gynaecological conditions experienced such marked improvements.
Again the present study elaborates on reasons for changes in pain levels in women, where previous studies can only report overall levels. Previous studies have variously suggested no change in pain for the women during the development of the partners ED, 22 and slight but not significant improvement in pain levels for women with partner treatment, 11 or a significant improvement in women's pain levels with partner treatment. 16 This study details how such findings can be explained by comparing FSFI and interview data. It is clinically important to understand that a woman's FSFI pain score can be indicative of her partner's ED, but could also be due to her own gynaecological problems. Where a woman experiences pain during sexual attempts, and anxiety is recognized as a contributing factor, both partners are likely to benefit from treatment with PDE5i. But if physical factors cause the woman's pain, treating her partner's ED would not alleviate her problems. These findings underscore the importance of including men's partners in assessment and treatment discussions when ED is the presenting problem.
This study has demonstrated a number of ways that FSFI data do not capture relevant aspects of the woman's experience in the context of ED treatment in a couple's relationship. Interviews can improve understanding of why a couple is experiencing difficulty, and better prepare clinicians to make suggestions for overcoming the problems. This study has shown how women experience positive change when their partners are again able to successfully interact sexually with them, boosting their sense of self, motivation for sexual engagement, and the couples' intimacy levels. Some couples found one PDE5i resulted in much more sexual satisfaction than another in their situation, and the questionnaire responses alone cannot capture reasons why this was so. Although this study is small in terms of the quantitative data, the mixed methods approach demonstrates how detailed information gained from interviews can, in the clinical context, improve understanding of the suitability of ED treatment for couples, and the likelihood that they will benefit from such therapy. Future studies in the area of sexual functioning should make use of detailed interviews as well as standardized questionnaires to further understand what underpins the overall findings.
